FDA Drug recall D-922-2013
0.9% Sodium Chloride Injection, USP, 100 mL flexible container, Rx only, Hospira, Inc
- FDA Drug
- Class I
- terminated
- Published 2013-09-04
On 2013-09-04 the FDA classified a Class I recall of 0.9% Sodium Chloride Injection, USP, 100 mL flexible container, Rx only, Hospira, Inc by Hospira, citing presence of Particulate Matter; product may contain fibrous material.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-922-2013 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2012-08-31 |
| Published | 2013-09-04 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira |
| Distribution | US |
Product
0.9% Sodium Chloride Injection, USP, 100 mL flexible container, Rx only, Hospira, Inc. Lake Forest, IL 60045 --- NDC 0409-7984-23
Reason
Presence of Particulate Matter; product may contain fibrous material
Identifiers
| code_info | Lot Number 05-201-JT, Expiration Date 1MAY2013 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-922-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.